Abstract
The meningococcal vaccine licensed for use in the United States protects against serogroups A, C, Y, and W- 135, but not against serogroup B. Although outbreaks of serogroup C have become more frequent nationwide, Oregon is the …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
